Industry says levies would hit supply chains, making medicines potentially unaffordable for some US patients
Americans would suffer most if Donald Trump imposed tariffs on imports of pharmaceuticals, as medications would become more expensive and potentially unaffordable for some people, drugmakers have warned.
Drugmakers have been braced for targeted border taxes – similar to the 25% levies on steel, aluminium and car imports – after the US president threatened to hit the sector and announced an investigation last month. Last week, Trump hinted at a possible reprieve for companies, saying they would be given time to move their operations to the US, But “after that it’s going to be a tariff wall put up, and they won’t be happy about it,” he added.
About Author
More Stories
BYD launches cheapest UK model in bid to overtake Tesla as biggest electric carmaker
Oil and gold prices soar and stock markets fall after Israel’s attacks on Iran
Trump trade deal shows how vital China’s rare-earth metals are to US defense firms